Redwood Park Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Redwood Park Advisors's AMGN Position: Q2 2026 in Review
Redwood Park Advisors increased its Amgen (AMGN) stake by 0.29% in Q2 2026, buying an estimated $685 and bringing the position to 702 shares worth $254K. The position accounts for 0.17% of the portfolio, ranked #42.
Redwood Park Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Redwood Park Advisors held 702 shares of Amgen worth $254K as of Q2 2026.
- Redwood Park Advisors bought 2 Amgen shares in Q2 2026, an estimated $685.
- Amgen made up 0.17% of Redwood Park Advisors's portfolio in Q2 2026, its #42 holding.
- Redwood Park Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.